Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

Kidney risk in heartburn drugs: research

Patients who take commonly prescribed drugs for heartburn for too long are at risk of developing serious kidney problems, new research has shown.

Commonly prescribed heartburn drugs may increase the risk of serious kidney damage, new research shows.

Scientists advised patients to use the drugs, known as proton pump inhibitors (PPIs), only when absolutely necessary and not for too long.

PPIs suppress production of acid in the stomach and are used to treat heartburn, acid reflux and gastric ulcers.

Each year millions of people in the UK are treated with the drugs, whose known side effects include nausea, vomiting, abdominal pain, headaches, diarrhoea and constipation.

Researchers who compared patients taking the medicines and histamine H2 blockers, another type of drug that reduces stomach acid, found a strong association between PPIs and declining kidney function.

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Over five years PPI users had a 28 per cent increased risk of developing chronic kidney disease and a 96 per cent greater risk of suffering kidney failure.

Patients who took PPIs for longer periods were more likely to experience kidney problems.

Lead scientist Dr Ziyad Al-Aly, from the VA Saint Louis Health Care System in the US, said: "The results emphasise the importance of limiting PPI use to only when it is medically necessary, and also limiting the duration of use to the shortest possible.

"A lot of patients start taking PPIs for a medical condition, and they continue much longer than necessary."

The research analysed information from national databases of the US Department of Veterans Affairs, identifying 173,321 new users of PPIs and 20,270 new users of histamine H2 receptor blockers.

Each group was followed up to see how their health fared over five years.

In 2013 an estimated 15 million Americans were prescribed PPIs, said the scientists whose findings are reported in the Journal of the American Society of Nephrology.

Five PPIs are licensed for use in the UK: esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole. Omeprazole and pantoprazole can be bought over the counter at pharmacies.


2 min read

Published

Source: AAP



Share this with family and friends


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world